Company news

Mayne Pharma Group Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

S&P DJI Announces June 2020 Quarterly Rebalance

June 11, 2020

MYX signs license agreement for contraceptive in Australia

May 28, 2020

Mayne Pharma submits NDA for E4/DRSP to the FDA

April 15, 2020

2020 Half Year Investor Presentation

February 20, 2020

2020 Half Year Media Release

February 20, 2020

2019 AGM CEOs Speech

November 21, 2019

E4/DRSP contraceptive presented at EU gynecology conference

October 22, 2019

MYX signs license agreement for novel oral contraceptive

October 1, 2019

2019 Full Year Results Investor Presentation

August 22, 2019

2019 Full Year Results Media Release

August 22, 2019

2019 Half Year Investor Presentation

February 21, 2019

2019 Half Year Media Release

February 21, 2019

Half Year Accounts

February 21, 2019

Tolsura (SUBA-itraconazole) capsule now launched in the US

January 29, 2019

FDA approval of Tolsura (SUBA-itraconazole) capsules

December 11, 2018

2018 AGM CEOs Speech

November 28, 2018

2018 AGM Chairmans Address

November 28, 2018

2018 Full Year Results Investor Presentation

August 23, 2018

2018 Full Year Results Media Release

August 23, 2018

Mayne Pharma acquires generic Efudex in the US

July 22, 2018

SUBA-Itraconazole NDA accepted for review by US FDA

May 1, 2018

Mayne Pharma opens new US manufacturing facility

April 17, 2018

Mayne Pharma launches Amiodarone 200mg tablets in the US

April 16, 2018

Mayne Pharmas generic NuvaRing accepted for filing by FDA

March 19, 2018

Mayne Pharma launches doxycycline IR capsules in the US

March 15, 2018

First generic launch of Ritalin LA 10mg capsules in the US

February 28, 2018

2018 Half Year Investor Presentation

February 22, 2018

2018 Half Year Media Release

February 22, 2018

2017 CEOs Speech

November 27, 2017

Mayne Pharma launches clozapine tablets in the US

November 8, 2017

Mayne Pharma adds two products to its Australian portfolio

September 14, 2017

FDA approval and first generic launch of Acticlate tablets

June 14, 2017

Clarification statement

May 2, 2017

Mayne Pharma acquires rights to generic Duragesic in the US

March 8, 2017

License and supply agreement for generic Nuvaring in the US

February 27, 2017

2017 Half Year Media Release

February 23, 2017

Mayne Pharma launches Butalbital / APAP tablets in the US

February 15, 2017

Mayne Pharma launches Amiodarone 100mg tablets

January 12, 2017

Mayne Pharma launches Fabior and Sorilux in the US

January 10, 2017

Update on Status of DOJ Investigation

December 15, 2016

S&P DJ Indices Announces March Quarterly Rebalance

November 7, 2016

MYX launches generic MS Contin (morphine sulfate) tablets

November 2, 2016

IDT: 1st generic proprietary prod shipped to US, temozolomide

November 1, 2016

MYX launches generic Entocort EC (Budesonide) capsules

October 26, 2016

Appendix 4E, Directors Report and Financial Statements

August 25, 2016

MYX announces acquisition of US foam dermatology assets

August 17, 2016

MYX announces settlement from patent infringement case

July 29, 2016

Completion institutional entitlement offer and placement

June 29, 2016

MYX announces acquisition of US generic product portfolio

June 27, 2016

MYX receives first generic approval of Tikosyn capsules

June 6, 2016

← Newer news releases · Older news releases →

Calls

Decks

The 5 newest of 90 decks. Every deck is listed under its year.